Soluble VE-cadherin (sVE-cadherin) was listed among the endothelial dysfunction markers related to endothelial inflammation, thrombosis, glycocalyx damage, vascular tone in COVID-19 patients (Xu et al., 2023). The gene discussed is CDH5; the disease is COVID-19.